Semi-Annual Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7298504

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
14,286,000,000 JPY
4,068,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-775,000,000 JPY
1,748,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-40,000,000 JPY
-2,000,000 JPY
Other comprehensive income
-816,000,000 JPY
1,745,000,000 JPY
Comprehensive income
13,469,000,000 JPY
5,814,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
13,469,000,000 JPY
5,814,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.